Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolia in Thalassemia Major and Osteoporosis
NCT02559648Phase 2Completed
- Start
- Sep 2014
- Primary completion
- Dec 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in osteoporosis. Started Sep 2014; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02559648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02559648.